Definitions, Causes, Diagnosis, Treatment, and Prevention.
View the illustration "What is drug resistance?"
Methicillin-Resistant Staphylococcus aureus (MRSA)Vancomycin-Resistant Enterococci (VRE)
The problem of antimicrobial (drug) resistance requires a multi-pronged research strategy. NIAID supports and conducts research on many aspects of antimicrobial (drug) resistance, from basic research on how microbes develop resistance to clinical trials that translate research from lab findings to potential treatments. NIAID works in concert with other federal agencies and partners with industry and nonprofit organizations to develop comprehensive programs aimed at controlling antimicrobial (drug) resistance.
NIAID’s Role in Addressing Antimicrobial ResistanceResearch GoalsCombating Drug Resistance with Basic ResearchTranslating Basic KnowledgeResearch in NIAID LabsPartnerships with federal agencies, industry, and nonprofit organizations
Scientific Literature: Reports, Plans, Journals, Findings
Services for Researchers: Resource Centers, Study Groups, Networks
Confronting the Challenge of Antimicrobial Resistance—March 10, 2008
Scientists Identify Factor Key to Severity of Community-Associated Methicillin-Resistant Staph Infections—Nov. 11, 2007
NIAID Media Availability: New Contracts Support Clinical Trials on Antibiotic-Resistant, Community-Acquired Staph Infections—August 9, 2007
Newly Found Sensing System Enables Certain Bacteria to Resist Human Immune Defenses—June 7, 2007
NIAID Media Availability: NIAID Releases MDR/XDR Tuberculosis Research Agenda—June 6, 2007
All News and Media
Otherwise healthy people of all ages are at risk of acquiring staph infections that are easier than ever to obtain and harder and harder to stop. Find out how two NIAID scientists are fighting back.
Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance on ClinicalTrials.gov.
View a list of links for more information about antimicrobial (drug) resistance.